Rifaximin in the treatment of recurrentClostridium difficileinfection
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Rifaximin in the treatment of recurrentClostridium difficileinfection
Authors
Keywords
-
Journal
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Volume 37, Issue 1, Pages 122-128
Publisher
Wiley
Online
2012-10-25
DOI
10.1111/apt.12111
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comparative Effectiveness ofClostridium difficileTreatments
- (2013) Dimitri M. Drekonja et al. ANNALS OF INTERNAL MEDICINE
- Systematic review: faecal transplantation for the treatment of Clostridium difficile-associated disease
- (2012) B. Guo et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Outcomes in community-acquired Clostridium difficile infection
- (2012) S. Khanna et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Predictors of severe outcomes associated with Clostridium difficile infection in patients with inflammatory bowel disease
- (2012) A. N. Ananthakrishnan et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- In VivoSelection of Rifamycin-Resistant Clostridium difficile during Rifaximin Therapy
- (2012) Robert J. Carman et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clostridium difficile Ribotype Does Not Predict Severe Infection
- (2012) Seth T. Walk et al. CLINICAL INFECTIOUS DISEASES
- Predictors of First Recurrence of Clostridium difficile Infection: Implications for Initial Management
- (2012) D. W. Eyre et al. CLINICAL INFECTIOUS DISEASES
- Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial
- (2012) Oliver A Cornely et al. LANCET INFECTIOUS DISEASES
- Systematic review: the use of proton pump inhibitors and increased susceptibility to enteric infection
- (2011) C. Bavishi et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Review article: faecal transplantation therapy for gastrointestinal disease
- (2011) J. Landy et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Comparative Susceptibilities to Fidaxomicin (OPT-80) of Isolates Collected at Baseline, Recurrence, and Failure from Patients in Two Phase III Trials of Fidaxomicin against Clostridium difficile Infection
- (2011) Ellie J. C. Goldstein et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Rifaximin: New Therapeutic Indication and Future Directions
- (2011) Anastasia Rivkin et al. CLINICAL THERAPEUTICS
- Clostridium difficile infection
- (2011) Andrea Lo Vecchio et al. CURRENT OPINION IN GASTROENTEROLOGY
- Rifaximin-Extended Intestinal Release Induces Remission in Patients With Moderately Active Crohn's Disease
- (2011) Cosimo Prantera et al. GASTROENTEROLOGY
- Fecal Transplantation, Through Colonoscopy, Is Effective Therapy for Recurrent Clostridium difficile Infection
- (2011) Eero Mattila et al. GASTROENTEROLOGY
- A randomized, double-blind, placebo-controlled pilot study to assess the ability of rifaximin to prevent recurrent diarrhoea in patients with Clostridium difficile infection
- (2011) K. W. Garey et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Multidrug resistance in European Clostridium difficile clinical isolates
- (2011) P. Spigaglia et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Divergent Rifamycin Susceptibilities of Clostridium difficile Strains in Canada and Italy and Predictive Accuracy of Rifampin Etest for Rifamycin Resistance
- (2011) M. A. Miller et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Rifaximin disc diffusion test for in vitro susceptibility testing of Clostridium difficile
- (2011) S. Huhulescu et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Fidaxomicin versus Vancomycin forClostridium difficileInfection
- (2011) Thomas J. Louie et al. NEW ENGLAND JOURNAL OF MEDICINE
- Best Strategies in Recurrent or Persistent Clostridium difficile Infection
- (2011) Christine S. Cocanour Surgical Infections
- Review article: rifaximin, a minimally absorbed oral antibacterial, for the treatment of travellers’ diarrhoea
- (2010) P. LAYER et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Antimicrobial susceptibility and heteroresistance in Chinese Clostridium difficile strains
- (2010) Haihui Huang et al. ANAEROBE
- Update on Clostridium difficile infection
- (2010) Caoilfhionn OʼDonoghue et al. CURRENT OPINION IN GASTROENTEROLOGY
- Clostridium difficileinfection: update on emerging antibiotic treatment options and antibiotic resistance
- (2010) Dhara Shah et al. Expert Review of Anti-Infective Therapy
- Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)
- (2010) Stuart H. Cohen et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- In vitro susceptibility of Clostridium difficile to rifaximin and rifampin in 359 consecutive isolates at a university hospital in Houston, Texas
- (2010) Z-D Jiang et al. JOURNAL OF CLINICAL PATHOLOGY
- Treatment with Monoclonal Antibodies againstClostridium difficileToxins
- (2010) Israel Lowy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rifaximin therapy for metronidazole-unresponsive Clostridium difficile infection: a prospective pilot trial
- (2010) P. Patrick Basu et al. Therapeutic Advances in Gastroenterology
- Typing and susceptibility of bacterial isolates from the fidaxomicin (OPT-80) phase II study for C. difficile infection
- (2009) D.M. Citron et al. ANAEROBE
- Rifaximin Redux: Treatment of recurrent Clostridium difficile infections with Rifaximin immediately post-vancomycin treatment
- (2009) Stuart Johnson et al. ANAEROBE
- Detection of virulence genes ofClostridium difficileby multiplex PCR
- (2009) JENNI ANTIKAINEN et al. APMIS
- High Frequency of Rifampin Resistance Identified in an EpidemicClostridium difficileClone from a Large Teaching Hospital
- (2009) Scott R. Curry et al. CLINICAL INFECTIOUS DISEASES
- European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI)
- (2009) M.P. Bauer et al. CLINICAL MICROBIOLOGY AND INFECTION
- Predictors of serious complications due toClostridium difficileinfection
- (2008) D. GUJJA et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Proton pump inhibitors increase significantly the risk ofClostridium difficileinfection in a low-endemicity, non-outbreak hospital setting
- (2008) B. R. DALTON et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Rifamycin Antibiotics for Treatment of Clostridium difficile–Associated Diarrhea
- (2008) Kevin W Garey et al. ANNALS OF PHARMACOTHERAPY
- Rifampin and Rifaximin Resistance in Clinical Isolates of Clostridium difficile
- (2008) J. R. O'Connor et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A randomized, double-blind study comparing Clostridium difficile immune whey and metronidazole for recurrent Clostridium difficile-associated diarrhoea: Efficacy and safety data of a prematurely interrupted trial
- (2008) Eero Mattila et al. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started